Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy

OBJECTIVE: We evaluate the predictive significance of the Advanced Lung Cancer Inflammation Index (ALI) in patients with advanced hepatocellular carcinoma (HCC) following therapy with immune checkpoint drugs. METHODS: In 2018-2020, 98 patients with advanced hepatocellular carcinoma who were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Ma, Fei, Wang, Ju feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043333/
https://www.ncbi.nlm.nih.gov/pubmed/36998452
http://dx.doi.org/10.3389/fonc.2023.997314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043333/
https://www.ncbi.nlm.nih.gov/pubmed/36998452
http://dx.doi.org/10.3389/fonc.2023.997314

Ejemplares similares